Patents by Inventor Julian G. Hurdle

Julian G. Hurdle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatments for gastrointestinal conditions
    Patent number: 10011589
    Abstract: Compounds for the treatment of bacterial and parasitic infections which are hybrid compounds of compounds having antibacterial or antiparasitic activity and compounds that decrease the absorption of the hybrid compound from the gastrointestinal tract. The compounds are preferably for use against C. difficile infections and comprise a hybrid molecule of an anti-C. difficile compound such as a nitroimidazole and a tetramic acid derivative.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: July 3, 2018
    Assignees: Board of Regents, The University of Texas System, St. Jude Children's Research Hospital, Inc.
    Inventors: Richard E. Lee, Philip T. Cherian, Julian G. Hurdle, Xiaoqian Wu
  • Treatments for Gastrointestinal Conditions
    Publication number: 20170073332
    Abstract: Compounds for the treatment of bacterial and parasitic infections which are hybrid compounds of compounds having antibacterial or antiparasitic activity and compounds that decrease the absorption of the hybrid compound from the gastrointestinal tract. The compounds are preferably for use against C. difficile infections and comprise a hybrid molecule of an anti-C. difficile compound such as a nitroimidazole and a tetramic acid derivative.
    Type: Application
    Filed: March 12, 2015
    Publication date: March 16, 2017
    Inventors: Richard E. Lee, Philip T. Cherian, Julian G. Hurdle, Xiaoqian WU
  • Spectinamides as anti-tuberculosis agents
    Patent number: 9284325
    Abstract: Novel 3?-deoxy-3?-acylaminospectinomycin compounds are described. Also described are methods of using the 3?-deoxy-3-acylaminospectinomycin compounds and other spectinomycin analogs in treating tuberculosis and in treating microbial infections.
    Type: Grant
    Filed: March 23, 2014
    Date of Patent: March 15, 2016
    Assignee: University of Tennessee Research Foundation
    Inventors: Richard E. Lee, Jianjun Qi, Julian G. Hurdle, Bernd Meibohm, VNR Pavan Kumar Vaddady, Rakesh, Jiuyu Liu
  • SPECTINAMIDES AS ANTI-TUBERCULOSIS AGENTS
    Publication number: 20140249155
    Abstract: Novel 3?-deoxy-3?-acylaminospectinomycin compounds are described. Also described are methods of using the 3?-deoxy-3-acylaminospectinomycin compounds and other spectinomycin analogs in treating tuberculosis and in treating microbial infections.
    Type: Application
    Filed: March 23, 2014
    Publication date: September 4, 2014
    Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Richard E. Lee, Jianjun Qi, Julian G. Hurdle, Bernd Meibohm, VNR Pavan Kumar Vaddady, Rakesh, Jiuyu Liu
  • Spectinamides as anti-tuberculosis agents
    Patent number: 8685978
    Abstract: Novel 3?-deoxy-3?-acylaminospectinomycin compounds are described. Also described are methods of using the 3?-deoxy-3-acylaminospectinomycin compounds and other spectinomycin analogs in treating tuberculosis and in treating microbial infections.
    Type: Grant
    Filed: July 26, 2010
    Date of Patent: April 1, 2014
    Assignee: University of Tennessee Research Foundation
    Inventors: Richard E. Lee, Jianjun Qi, Julian G. Hurdle, Bernd Meibohm, Vnr Pavan Kumar Vaddady, Rakesh, Jiuyu Liu